a public good project by the
Synthesis
Company
of California

© 2026

Yu Wang | doi.page

0 works0 citations0 h-index

Yu Wang

Cangzhou Central Hospital(CN)Vanderbilt University Medical Center(US)

Publications by Year

Research Areas

Liver Disease Diagnosis and Treatment, Pluripotent Stem Cells Research, 3D Printing in Biomedical Research, Hepatocellular Carcinoma Treatment and Prognosis, CRISPR and Genetic Engineering

Most-Cited Works

→ Generation of human induced pluripotent stem cells from urine samples(2012)611 cited
→ Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived Hepatocytes(2015)148 cited
→ Regulation of Set9-Mediated H4K20 Methylation by a PWWP Domain Protein(2009)124 cited
→ Csi1 links centromeres to the nuclear envelope for centromere clustering(2012)96 cited
→ Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats(2012)95 cited
→ Laparoscopic hepatectomy versus radiofrequency ablation for minimally invasive treatment of single, small hepatocellular carcinomas(2015)89 cited

→ Antioxidant Supplementation Reduces Genomic Aberrations in Human Induced Pluripotent Stem Cells(2014)

86 cited

→ Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis(2015)80 cited

→ Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation(2018)72 cited

→ Structural and functional cerebral impairments in cirrhotic patients with a history of overt hepatic encephalopathy(2011)70 cited